News + Filings Transactions
|
Davis Aaron I.
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/09/2023 | Rain Oncology Inc. | RAIN | Grant | Stock Option (Right to Buy) | 35k | $1.21 | $42.4k | | 08/09/2023 |
| 06/13/2023 | iTeos Therapeutics, Inc. | ITOS | Grant | Stock Option (Right to Buy) | 22.4k | $14.77 | $330.6k | | 06/13/2023 |
| 06/06/2023 | Tango Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 30k | $3.55 | $106.5k | | 06/06/2023 |
| 06/06/2023 | Tango Therapeutics, Inc. | | Grant | Common Stock | 5k | $0.00 | $0 | | 06/06/2023 |
| 01/20/2023 | Mirati Therapeutics, Inc. | MRTX | Grant | Common Stock | 4.4k | $0.00 | $0 | | 01/20/2023 |
| 01/20/2023 | Mirati Therapeutics, Inc. | MRTX | Grant | Non Qualified Stock Option (right to buy) | 7.5k | $45.66 | $343.4k | | 01/20/2023 |
| 11/04/2022 | Rain Oncology Inc. | RAIN | Purchase | Non-Voting Common Stock | 400k | $5.83 | $2.3M | See footnote | 11/04/2022 |
| 11/04/2022 | Rain Oncology Inc. | RAIN | Purchase | Common Stock | 972.2k | $5.83 | $5.7M | See footnote | 11/04/2022 |
| 06/09/2022 | iTeos Therapeutics, Inc. | ITOS | Grant | Stock Option (Right to Buy) | 17.5k | $18.78 | $329.4k | | 06/09/2022 |
| 06/08/2022 | Tango Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 40k | $5.90 | $236k | | 06/08/2022 |
| 06/01/2022 | Rain Oncology Inc. | RAIN | Grant | Stock Option (Right to Buy) | 20k | $2.44 | $48.8k | | 06/01/2022 |
| 05/11/2022 | iTeos Therapeutics, Inc. | ITOS | Sale | Common Stock | 337.1k | $18.25 | $6.2M | See footnote | 05/09/2022 |
| 05/11/2022 | iTeos Therapeutics, Inc. | ITOS | Sale | Common Stock | 891 | $17.53 | $15.6k | See footnote | 05/09/2022 |
| 05/10/2022 | iTeos Therapeutics, Inc. | ITOS | Sale | Common Stock | 4.8k | $24.77 | $120.1k | See footnote | 05/09/2022 |
| 05/10/2022 | iTeos Therapeutics, Inc. | ITOS | Sale | Common Stock | 95.2k | $25.18 | $2.4M | See footnote | 05/09/2022 |
| 05/09/2022 | iTeos Therapeutics, Inc. | ITOS | Sale | Common Stock | 200k | $23.47 | $4.7M | See footnote | 05/09/2022 |
| 05/09/2022 | iTeos Therapeutics, Inc. | ITOS | Sale | Common Stock | 25k | $22.91 | $572.7k | See footnote | 05/09/2022 |
| 05/02/2022 | iTeos Therapeutics, Inc. | ITOS | Sale | Common Stock | 7.3k | $26.91 | $196.4k | See footnote | 04/28/2022 |
| 05/02/2022 | iTeos Therapeutics, Inc. | ITOS | Sale | Common Stock | 92.7k | $27.53 | $2.6M | See footnote | 04/28/2022 |
| 04/29/2022 | iTeos Therapeutics, Inc. | ITOS | Sale | Common Stock | 10k | $28.22 | $282.2k | See footnote | 04/28/2022 |
| 04/29/2022 | iTeos Therapeutics, Inc. | ITOS | Sale | Common Stock | 115k | $27.01 | $3.1M | See footnote | 04/28/2022 |
| 04/28/2022 | iTeos Therapeutics, Inc. | ITOS | Sale | Common Stock | 150k | $27.40 | $4.1M | See footnote | 04/28/2022 |
| 03/23/2022 | iTeos Therapeutics, Inc. | ITOS | Purchase | Common Stock | 20k | $32.85 | $657k | See footnote | 03/22/2022 |
| 03/22/2022 | iTeos Therapeutics, Inc. | ITOS | Purchase | Common Stock | 5k | $33.43 | $167.1k | See footnote | 03/22/2022 |
| 03/22/2022 | iTeos Therapeutics, Inc. | ITOS | Purchase | Common Stock | 3.7k | $33.09 | $122.4k | See footnote | 03/22/2022 |
| 03/22/2022 | iTeos Therapeutics, Inc. | ITOS | Purchase | Common Stock | 21.3k | $31.88 | $678.9k | See footnote | 03/22/2022 |
| 01/14/2022 | Mirati Therapeutics, Inc. | MRTX | Grant | Non Qualified Stock Option (right to buy) | 3.7k | $124.31 | $458.5k | | 01/14/2022 |
| 01/14/2022 | Mirati Therapeutics, Inc. | MRTX | Grant | Common Stock | 2.5k | $0.00 | $0 | | 01/14/2022 |
| 11/19/2021 | Odonate Therapeutics, Inc. | ODT | Sale | Common Stock | 30k | $1.92 | $57.5k | | 11/17/2021 |
| 11/19/2021 | Odonate Therapeutics, Inc. | ODT | Sale | Common Stock | 150k | $1.84 | $276.3k | See footnote | 11/17/2021 |
| 11/18/2021 | Odonate Therapeutics, Inc. | ODT | Sale | Common Stock | 250k | $1.95 | $487.2k | See footnote | 11/17/2021 |
| 11/17/2021 | Odonate Therapeutics, Inc. | ODT | Sale | Common Stock | 170k | $2.23 | $379.7k | | 11/17/2021 |
| 11/17/2021 | Odonate Therapeutics, Inc. | ODT | Sale | Common Stock | 600k | $2.17 | $1.3M | See footnote | 11/17/2021 |
| 06/17/2021 | iTeos Therapeutics, Inc. | ITOS | Grant | Stock Option (Right to Buy) | 16.6k | $26.03 | $432.3k | | 06/17/2021 |
| 01/15/2021 | Mirati Therapeutics, Inc. | MRTX | Grant | Common Stock | 1.5k | $0.00 | $0 | | 01/15/2021 |
|
|